Effects of bilirubin and sera from jaundiced patients on osteoblasts: Contribution to the development of osteoporosis in liver diseases

Hepatology

Volumn 54, Issue 6, 2011, Pages 2104-2113

  Ruiz Gaspà, Silvia ^a,b   Martinez Ferrer, Angels ^a,b   Guañabens, Nuria ^a,b   Dubreuil, Marta ^a,b   Peris, Pilar ^a,b   Enjuanes, Anna ^b   Martinez de Osaba, Maria Jesús ^a,b   Alvarez, Luisa ^a,b   Monegal, Ana ^a,b   Combalia, Andrés ^b   Parés, Albert ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TRANSCRIPTION FACTOR RUNX2;

ARTICLE; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION; HUMAN; HUMAN CELL; JAUNDICE; LIVER DISEASE; OSTEOBLAST; OSTEOCLASTOGENESIS; OSTEOPOROSIS; OSTEOSARCOMA CELL; PRIORITY JOURNAL; SERUM; UPREGULATION;

BILIRUBIN; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DOWN-REGULATION; HUMANS; JAUNDICE; OSTEOBLASTS; OSTEOPOROSIS; OSTEOSARCOMA; RANK LIGAND; UP-REGULATION;

EID: 82455162634     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24605     Document Type: Article

References (27)

1. Guañabens N, Parés A. Liver and bone. Arch Biochem Biophys 2010; 503: 84-94.
2. Collier J. Bone disorders in chronic liver disease. HEPATOLOGY 2007; 46: 1271-1278.
3. Guañabens N, Parés A, Mariñoso L, Brancós MA, Piera C, Serrano S, et al. Factors influencing the development of metabolic bone disease in primary biliary cirrhosis. Am J Gastroenterol 1990; 85: 1356-1362.
4. Guichelaar MM, Malinchoc M, Sibonga J, Clarke BL, Hay JE. Bone metabolism in advanced cholestatic liver disease: analysis by bone histomorphometry. HEPATOLOGY 2002; 36: 895-903.
5. Janes CH, Dickson ER, Okazaki R, Bonde S, McDonagh AF, Riggs BL. Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest 1995; 95: 2581-2586.
6. Ruiz-Gaspà S, Guañabens N, Enjuanes A, Peris P, Martinez-Ferrer A, de Osaba MJ, et al. Lithocholic acid downregulates vitamin D effects in human osteoblasts. Eur J Clin Invest 2010; 40: 25-34.
7. Menon KV, Angulo P, Weston S, Dickson ER, Lindor KD. Bone disease in primary biliary cirrhosis: independent indicators and rate of progression. J Hepatol 2001; 35: 316-323.
8. Guañabens N, Parés A, Ros I, Caballería L, Pons F, Vidal S, et al. Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis. J Hepatol 2005; 42: 573-577.
9. Guañabens N, Cerdá D, Monegal A, Pons F, Caballería L, Peris P, et al. Low bone mass and severity of cholestasis affect fracture risk in patients with primary biliary cirrhosis. Gastroenterology 2010; 138: 2348-2356.
10. Weinreb M, Pollak RD, Ackerman Z. Experimental cholestatic liver disease through bile-duct ligation in rats results in skeletal fragility and impaired osteoblastogenesis. J Hepatol 2004; 40: 385-390.
11. Smith DL, Shire NJ, Watts NB, Schmitter T, Szabo G, Zucker SD. Hyperbilirubinemia is not a major contributing factor to altered bone mineral density in patients with chronic liver disease. J Clin Densitom 2006; 9: 105-113.
12. Minuk GY, Greenberg R, Uhanova J, Hawkins K, Leslie WD. Bone mineral densities in individuals with Gilbert's syndrome: a cross-sectional, case-control pilot study. Can J Gastroenterol 2009; 23: 431-436.
13. Duff TA, Feilbach JA, Yusuf Q, Scott G. Bilirubin and the induction of intracranial arterial spasm. J Neurosurg 1988; 69: 593-598.
14. Trost GR, Nagatani K, Goknur AB, Haworth RA, Odell GB, Duff TA. Bilirubin levels in subarachnoid clot and effects on canine arterial smooth muscle cells. Stroke 1993; 24: 1241-1245.
15. Robey PG, Termine JD. Human bone cells in vitro. Calcif Tissue Int 1985; 37: 453-460.
16. Hernandez MV, Guañabens N, Alvarez L, Monegal A, Peris P, Riba J et al. Immunocytochemical evidence on the effects of glucocorticoids on type I collagen synthesis in human osteoblastic cells. Calcif Tissue Int 2004; 74: 284-293.
17. Fedde KN. Human osteosarcoma cells spontaneously release matrix-vesicle-like structures with the capacity to mineralize. Bone Miner 1992; 17: 145-151.
18. Hale LV, Ma YF, Santerre RF. Semi-quantitative fluorescence analysis of calcein binding as a measurement of in vitro mineralization. Calcif Tissue Int 2000; 67: 80-84.
19. Muthusami S, Senthilkumar K, Vignesh C, Ilangovan R, Stanley J, Selvamurugan N, et al. Effects of Cissus quadrangularis on the proliferation, differentiation and matrix mineralization of human osteoblast like SaOS-2 cells. J Cell Biochem 2011; 112: 1035-1045.
20. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
21. Vassilopoulou-Sellin R, Rey-Bear N, Oyedeji CO. Bilirubin as an inhibitor of cartilage metabolism: effect on avian chondrocyte proliferation in cell culture. J Bone Miner Res 1990; 5: 769-774.
22. Lin TH, Tang CH, Hung SY, Liu SH, Lin YM, Fu WM, et al. Upregulation of heme oxygenase-1 inhibits the maturation and mineralization of osteoblasts. J Cell Physiol 2010; 222: 757-768.
23. Stocker R, Ames BN. Potential role of conjugated bilirubin and copper in the metabolism of lipid peroxides in bile. Proc Natl Acad Sci U S A 1987; 84: 8130-8134.
24. Doré S, Snyder SH. Neuroprotective action of bilirubin against oxidative stress in primary hippocampal cultures. Ann N Y Acad Sci 1999; 890: 167-172.
25. Jansen T, Hortmann M, Oelze M, Opitz B, Steven S, Schell R, et al. Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin. J Mol Cell Cardiol 2010; 49: 186-195.
26. Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 2005; 115: 3318-3325.
27. Stellon AJ, Webb A, Compston J, Williams R. Low bone turnover state in primary biliary cirrhosis. HEPATOLOGY 1987; 7: 137-142.